Total Wealth Planning & Management Inc. purchased a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 5,026 shares of the company's stock, valued at approximately $594,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of CAH. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health in the 4th quarter valued at approximately $26,000. Promus Capital LLC purchased a new position in shares of Cardinal Health during the 4th quarter valued at $30,000. Bellwether Advisors LLC acquired a new position in shares of Cardinal Health in the fourth quarter worth $32,000. Lee Danner & Bass Inc. purchased a new stake in shares of Cardinal Health during the fourth quarter worth $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health during the fourth quarter valued at $36,000. 87.17% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms have commented on CAH. JPMorgan Chase & Co. boosted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Argus set a $148.00 price objective on shares of Cardinal Health in a research note on Tuesday, February 4th. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Wells Fargo & Company boosted their price target on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Finally, Mizuho increased their price objective on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $146.43.
Read Our Latest Stock Analysis on CAH
Cardinal Health Stock Up 0.3%
Shares of CAH stock traded up $0.47 during mid-day trading on Friday, reaching $154.46. 2,759,499 shares of the stock traded hands, compared to its average volume of 2,229,193. The stock's fifty day simple moving average is $141.26 and its two-hundred day simple moving average is $130.05. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $156.44. The company has a market cap of $36.87 billion, a price-to-earnings ratio of 28.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.08 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.32%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.